Related content

Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein 2 (rhBMP-2). A pilot study in dogs

By Becker Jürgen   Kirsch Axel   Schwarz Frank   Chatzinikolaidou Maria   Rothamel Daniel   Lekovic Vojislav   Laub Markus   Jennissen Herbert  

Clinical Oral Investigations, Vol. 10, Iss. 3, 2006-09 ,pp. : 225-225

Springer Publishing Company

Access to resources Recommend Favorite

Effect of recombinant human bone morphogenetic protein-2 on the osseointegration of dental implants: a biomechanics study

By Sykaras Nikitas   Iacopino Anthony   Triplett Robert   Marker Victoria  

Clinical Oral Investigations, Vol. 8, Iss. 4, 2004-12 ,pp. : 196-205

Springer Publishing Company

Access to resources Recommend Favorite

Effect of enamel matrix protein derivative on the attachment, proliferation, and viability of human SaOs₂ osteoblasts on titanium implants

By Schwarz Frank   Rothamel Daniel   Herten Monika   Sculean Anton   Scherbaum Werner   Becker Jürgen  

Clinical Oral Investigations, Vol. 8, Iss. 3, 2004-09 ,pp. : 165-171

Springer Publishing Company

Access to resources Recommend Favorite

Homeobox protein MSX‐1 inhibits expression of bone morphogenetic protein 2, bone morphogenetic protein 4, and lymphoid enhancer‐binding factor 1 via Wnt/β‐catenin signaling to prevent differentiation of dental mesenchymal cells during the late bell stage

By  

European Journal of Oral Sciences, Vol. 126, Iss. 1, 2018-02 ,pp. : 1-12

John Wiley & Sons Inc

Access to resources Recommend Favorite

Histological and immunohistochemical analysis of initial and early subepithelial connective tissue attachment at chemically modified and conventional SLA®titanium implants. A pilot study in dogs

By Schwarz Frank   Herten Monika   Sager Martin   Wieland Marco   Dard Michel   Becker Jürgen  

Clinical Oral Investigations, Vol. 11, Iss. 3, 2007-09 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite